Bioventus Launches DUROLANE® in the US DURHAM, NC - March 5, 2018 – Bioventus, a global leader in orthobiologic solutions, today launched DUROLANE, it [...]

Bioventus to Co-Develop Next Generation Bone Allograft with LifeLink DURHAM, NC – February 26, 2018 – Bioventus, a global leader in orthobiologic solu [...]

Bioventus to Continue Distributing SUPARTZ FX™ Through 2028 DURHAM, NC - February 12, 2018 – Bioventus, a global leader in orthobiologic solutions, ha [...]

Additional Strategic Funding for CartiHeal's Ongoing AGILI-C™ IDE Clinical Study $2.5M boost by Bioventus brings latest investment round to $21M KFAR [...]

Bioventus Launches New Website for EXOGEN® DURHAM, NC– January 25, 2018 – Bioventus, a global leader in orthobiologics, today has launched a new versi [...]

Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN® Durham, NC– September 13, 2017 – Bioventus, a global leader in orthobiologics, [...]

Bioventus Receives US FDA Approval for DUROLANE® Durham, NC- September 5, 2017 – Bioventus, a global leader in orthobiologic solutions, today announce [...]

Bioventus Names Greg Anglum Senior Vice President and Chief Financial Officer, Tony D’Adamio Senior Vice President and General Counsel Durham, NC- Aug [...]

Bioventus Expands EXOGEN® Performance Program in Canada to Include All Fracture Types Mississauga, Ontario, Canada – July 17, 2017 – Bioventus, a glob [...]

Bioventus Surgical Expands Portfolio Offering with Premier DURHAM, NC – June 7, 2017 – Bioventus, a global leader in orthobiologics, today announced t [...]